XVIR
DEAD

Serial Number

86365333

Owner

XVir Therapeutics GmbH

Attorney

LISA V MUELLER

Filing Date

Aug 13, 2014

Add to watchlist:

No watchlists yet
View on USPTO

XVIR Trademark

Serial Number: 86365333 • Registration: 4843889

XVIR is a trademark filed by XVir Therapeutics GmbH on August 13, 2014. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

XVir Therapeutics GmbH (5 trademarks)

Nymphenburger Str. 1
Munich D080335 , DE

Entity Type: 16

Trademark Details

Filing Date

August 13, 2014

Registration Date

November 3, 2015

Published for Opposition

January 13, 2015

Cancellation Date

May 13, 2022

Goods & Services

Scientific laboratory equipment, namely, photometers, mass spectrometers, ELISA readers, positron emission tomography (PET) scanners, thermocyclers, nuclear magnetic resonance (NMR) spectrometers, fluorescence-activated cell sorters, cell counters, and blotting devices using electric, magnetic, or capillary forces for material transfer

Chemical products for medical and veterinary clinical use, namely nucleic acids, vectors, plasmids, viruses, peptides and proteins, lipids, lipid coated proteins, lipid coated nucleic acids, lipid coated viruses, lipid coated vectors, lipid coated plasmids, antibodies, anticalines, aptamers, spiegelmers, siRNA molecules, antisense oligonucleotides, ribosomes, decoy oligonucleotides; Pharmaceutical and veterinary preparations, namely slimming agents, appetite suppressants, acidosis therapeutics, analeptics, antihypoximics, analgesics, antirheumatic drugs, antihelmintics, antiallergics, anti-anemia drugs, antiarrhythmics, antibiotics, anti-infective agents, antidementics, nootropics, antidiabetics, antidotes, antiemetics, antivertiginosics, antiepileptics, antihemorrhagics, antifibrinolytics, hemostatics, antihypertonics, antihypoglycemics, antihypotonics, anticoagulants, antimycotics, antiparasitic agents, antiphlogistics, expectorants, agents for use in atherosclerosis, balneotherapeutics and preparations for heat therapy, beta receptor blocking agents, calcium channel blocking agents and inhibitors of the renin-angiotensin-system, broncholytics, antiasthmetics, cholagoguegics and biliary tract therapeutics, cholinergics, corticoids, dermatics, general purpose disinfectants, antiseptics, dietetic foods adapted for medical use, alimentary therapeutics, diagnostic preparations for medical and veterinary use, diuretics, preparations for the stimulation of blood circulation, fibrinolytics, geriatric agents for the treatment of stress and age-related diseases, geriatric nutritional supplements, agents for use in gout, agents for use in flu and in catarrhal fever, gynecological agents, hemorrhoid agents, hepatics, hypnotics, sedatives, cardiac therapeutics, agents for removal of dental stain, agents for reconstitution of gums, materials for dental fillings and for dental sealing purposes, corona agents, laxatives, antilipaemics, local anesthetics, neural therapeutics, gastro-intestinal agents, migraine agents, mineral supplements, mouth and pharyngeal therapeutics, muscle relaxants, narcotics, neuropathical agents and other neurotropic agents, ophthalmic preparations, agents for use in osteoporosis, calcium metabolism modifying agents, agents for use in Parkinson's Disease and other agents against disturbances of the extrapyramidal system, psychotropic agents, rhinologics, sinositic agents, roborants, thyroidal therapeutics, spasmolytics, inhibitors of thrombocyte aggregation, tuberculosis agents, altemants, urologics, venous agents, vitamins, cytostatics and other antineoplastic agents and protectives, homeopathic supplements; and Pharmaceutical and veterinary preparations in the nature of viruses, viruses for oncolysis, viruses for gene therapy, viruses for delivery of pharmaceutically active compounds, viruses for restoration of drug sensitivity, viruses for restoration of apoptosis, and viruses for cancer therapy, all for clinical use

Chemical products for research use and for use in the manufacture of pharmaceuticals, namely nucleic acids, vectors, plasmids, viruses, peptides and proteins, lipids, lipid coated proteins, lipid coated nucleic acids, lipid coated viruses, lipid coated vectors, lipid coated plasmids, antibodies, anticalines, aptamers, aptamers consisting essentially of L-nucleotides, short limiting RNA molecules without specific limitation to the number of nucleotides, antisense oligonucleotides, ribozymes, decoy oligonucleotides

Medical services featuring physicians and surgeons; veterinary services; medical services, namely, determination of individual disease risk, determination of individual cancer therapy, identifying patient groups treatable by oncolytic viruses, individual health care and managed health care services

Scientific and medical research services in biology, molecular biology, chemistry, biochemistry, genetics, molecular genetics, and pathology; scientific and medical research services for third parties, namely, determination of viral particles, determination and sequencing of viral genome, determination of nuclear YB-1 binding protein, determination of drug resistance in samples, determination of radiation resistance in samples, design of viral vectors, design of plasmid vectors, design of viruses and in particular oncolytic viruses; scientific and medical research services, namely, design and performance of clinical trials

Filing History

CANCELLED SEC. 8 (6-YR)
May 13, 2022 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Nov 3, 2020 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 5, 2017 TCCA
REGISTERED-PRINCIPAL REGISTER
Nov 3, 2015 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Sep 29, 2015 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 15, 2015 AITU
NOTICE OF ALLOWANCE CANCELLED
Aug 12, 2015 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Aug 12, 2015 D1BR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 10, 2015 NOAM
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 6, 2015 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 6, 2015 REAP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 13, 2015 NPUB
PUBLISHED FOR OPPOSITION
Jan 13, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 24, 2014 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 1, 2014 CNSA
ASSIGNED TO EXAMINER
Nov 30, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 22, 2014 NWOS
NEW APPLICATION ENTERED
Aug 16, 2014 NWAP